Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy

Launched by VASTRA GOTALAND REGION · Aug 8, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at two different ways to treat a serious eye condition called proliferative diabetic retinopathy (PDR), which can lead to blindness in people with diabetes. Researchers want to find out if it's better to have one treatment session or multiple sessions of a procedure called panretinal photocoagulation (PRP). This treatment helps to stop the growth of abnormal blood vessels in the eye that can cause vision problems.

To participate in this study, you need to be at least 18 years old and have type 1 or type 2 diabetes with newly diagnosed PDR. Your vision must be good enough for the treatment, and your eye needs to be in good condition for the procedure. If you’ve had recent eye surgeries or certain other eye conditions, you might not qualify. If you do participate, you can expect to receive either the single-session or multiple-session treatment and help researchers understand which method works better for patients like you. The study is currently recruiting participants, and everyone is welcome, regardless of gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \> 18 years.
• • Patients with type 1 or type 2 Diabetes Mellitus with newly diagnosed Proliferative Diabetic Retinopathy, PDR.
• • Visual acuity ≥ 0.1 Snellen.
• • CRT of less than 300 micrometer measured by OCT without cysts in the neuroretina.
• • Clear media and adequately dilated pupil for PRP.
• Exclusion Criteria:
• • Intraocular surgery within the last 4 months or planned within the next 3 months.
• • Previous or current center-involved diabetic macular edema (Ci-DME).
• • Previous PRP, intravitreal treatment (IVT), or macular laser treatment in study eye.
• • Treatment with medications known to risk macular edema.
• • Media opacity preventing adequate PRP.
• • General medical condition making office laser treatment very difficult or impossible.